Tuesday, December 19, 2017 1:10:57 PM
Business Description
The Company is now in process of seeking a merger or acquisition candidate. Effective October 9, 2017 the PSA Agreement with Cantech Pharma, inc. has been rescinded do inability to proceed with the license for Mexico that previously had focused on its immunotherapeutic based technology specific to Cancer indication. Cantech Holding, Inc., f/k/a Reve Technologies, Inc., f/k/a Bassline Productions, Inc. was formerly involved as an immunotherapeutic based technology company focused on investing in development of, manufacture and commercialization of its then lead product Irreversible Pepsin Fraction (IPF) specific to the Cancer indication only, exclusively licensed for the United Mexican States.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM